ACTH (22-39) is an adrenocorticotropic hormone (ACTH) fragment. ACTH (22-39) is the 22-39 sequence of ACTH.
CAT No: R1156
CAS No:37548-29-1
Synonyms/Alias:37548-29-1;22-39-ACTH (human);EX-A7455;MFCD00076176;FA108797;ACTH (22-39) (H-L-Val-L-Tyr-L-Pro-L-Asn-Gly-L-Ala-L-Glu-L-Asp-L-Glu-L-Ser-L-Ala-L-Glu-L-Ala-L-Phe-L-Pro-L-Leu-L-Glu-L-Phe-OH);H-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe-OH; H-VYPNGAEDESAEAFPLEF-OH;
1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More